摘要 |
HA161C MEDICAMENTS FOR TREATING GASTROINTESTlNAL DISORDERS, The use is described of both (i) ranitidine bismuth citrate and (ii) one or moreHelicobacter pylori-inhibiting antibiotics in treating or preventing gastrointestinal disorders. Pharmaceutical compositions containing both (i) and (ii) and methods for the preparation of pharmaceutical compositions containing (i) and (ii) are also described. |